The decisions made at the NENC Clinical Effectiveness and Governance (CEG) Subcommittee October 2024 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/

This includes the recommendations made by NTAG at its September 2024 meeting and NICE Technology appraisals from the 1st June 2024 to 31st July 2024.

The following guidelines/position statements were approved and can be found at:

  • Emollient Prescribing Guideline and Formulary North East and North Cumbria – new – https://ntag.nhs.uk/guidelines/
  • NENC Menopause guidance – updated – https://ntag.nhs.uk/guidelines/
  • NENC Clinical Pain Network Position Statement on Chronic Pain Guidelines – new – https://ntag.nhs.uk/guidelines/
  • North of Tyne Gateshead & North Cumbria Urinary Continence Enablement Products and Devices Formulary 2024 – new – https://ntag.nhs.uk/guidelines/
  • Guidelines for the appropriate prescribing of Oral Nutritional Supplementation in the management of adults at risk of undernutrition in primary care – final approved version to follow.
  • NENC Guideline – Management of Hypomagnesaemia in adults – final approved version to follow.